Galaxy Surfactants — Management Says Supply Issues To Normalise From FY23: Nirmal Bang
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Nirmal Bang Report
Management highlighted that unavailability of key raw materials, further increase in freight costs and elongated supply chain cycle affected the latest quarterly performance.
While availability issue in India has now been resolved, GALSURF imports ~60% of the RMs from overseas markets and 2/3rd of the revenue is also derived from the overseas markets.
Therefore, while we expect sequential improvement in EBITDA/kg, efficient pass-through w.r.t. RM and freight costs might take 1-2 more quarters. Management reiterated that underlying demand across geographies continues to remain robust.
We continue to remain positive on the business opportunity considering the structural shift from synthetic to natural chemicals globally and GALSURF has presence across the HPC segment in all geographies and has developed very strong customer relationships.
We are building in Revenue/EBITDA/APAT CAGR of 5%/15%/15% over FY22E-24E. We maintain Buy rating on GALSURF with an unchanged target price
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.